Komori
Nihon Nohyaku (4997) · RiskMaterialised

Delayed Sales of Orthosulfamuron and Impairment of Acquisition-Related Goodwill

First written in FY2017. 1 of 1 entries say "Materialised", first in FY2017. Latest entry: FY2017.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Impairment of Goodwill and Trademark Rights Associated with AcquisitionsA theme 204 companies write about · 206 as a headwind · 0 as a tailwind

Nihon Nohyaku moved to the "Worse" side of this theme in 2017, 7 years before the typical company in this theme (2024).

The whole theme swung hardest in 2023: 36 of 99 companies on the "Worse" side.

52 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 206 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2017MaterialisedAnnual report

    「Because sales performance has remained substantially below the initial plan, partly due to the effect of distribution inventories in the countries where the product is sold, the entire goodwill balance has been recorded as an impairment loss under extraordinary losses.」

    Sales of the acquired herbicide orthosulfamuron fell substantially below plan, and the full ¥547 million goodwill balance was recorded as an impairment loss.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nihon Nohyaku yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Delayed Sales of Orthosulfamuron and Impairment of Acquisition-Related Goodwill | NIHON NOHYAKU CO.,LTD. (4997) | Komori